iTeos Therapeutics Completes $75 Million Series B Financing

iTeos Therapeutics Completes $75 Million Series B Financing   Oversubscribed financing round led by ...

Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement

TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL) (“Trillium” or ...

VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a ...

VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a ...